Mendelian: Funding, Investors & Team (Aug 2026)
Mendelian is a platform that aids medical professionals in expediently identifying uncommon genetic ailments. By utilizing the clinical characteristics of patients, Mendelian can pinpoint which genes are in charge of these rare diseases. The platform's sophisticated agent examines the phenotypic features of the patient that have been provided by a doctor and records which specific genes and mutations are the root cause. Consequently, this presents an innovative method for researching cases that have yet to be diagnosed.
Mendelian has raised $1.7M across 1 funding round on record, the most recent an undisclosed round of $1.7M announced in Mar 2023.
That round is below the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Mendelian Company Profile and Key Stats
Latest funding round on record: Mar 2023.
Mendelian Funding Rounds
Mendelian Founders and Leadership Team
Contact details for the Mendelian team: 1 of 1 has an email address on file.
Start 14-day free trial →Mendelian Funding Compared to Other Health Care Startups
Mendelian's latest round of $1.7M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Mendelian in Health Care and London
Companies Similar to Mendelian
Renata Medical develops purposeful medical devices for unmet pediatric needs.
Leo Cancer Care provides a streamlined and effective treatment method that empowers patients and instills…
Neubond develops wearable devices for stroke mobility rehabilitation. These devices provide autonomous…
Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
Nebu-Flow is a manufacturer of the next generation of inhaled drugs for patients with respiratory disorders.…
iFAST is addressing the Antimicrobial Susceptibility Testing market, reducing the spread of antimicrobial…
Innovative medical gadgets are created by Creo Medical Limited, situated in Chepstow, South Wales. With a…
TympaHealth has developed the world's first ear and hearing health assessment system. The Tympa system…
NEX Health Intelligence (NEX) is a health-tech business that develops AI-powered software for hospitals to…
Infex Therapeutics acquire, develop and license drugs to treat pandemic infections.
Asterix Health is the workforce solution for modern healthcare.
Gloucester Rugby is a professional English rugby union club that gives up to date with all the information…
Mendelian Funding FAQs
What does Mendelian do?
Mendelian is a platform that aids medical professionals in expediently identifying uncommon genetic ailments. By utilizing the clinical characteristics of patients, Mendelian can pinpoint which genes are in charge of these rare diseases. The platform's sophisticated agent examines the phenotypic features of the patient that have been provided by a doctor and records which specific genes and mutations are the root cause. Consequently, this presents an innovative method for researching cases that have yet to be diagnosed.
How much funding has Mendelian raised?
Mendelian has raised $1.7M across 1 round on record. The most recent is an undisclosed round of $1.7M announced in Mar 2023.
When did Mendelian last raise funding?
Mendelian's most recent funding round on record is an undisclosed round of $1.7M, announced in Mar 2023.
Who founded Mendelian?
FundedIQ lists Fran Garcia (Founder) at Mendelian.
Where is Mendelian headquartered?
Mendelian is based in London, England, United Kingdom.
How many employees does Mendelian have?
Mendelian is in the 11-50 employee band.
How does Mendelian's funding compare to other Health Care startups?
Mendelian's latest round of $1.7M is below the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Mendelian Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Mendelian is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.